Memantine vs Trastuzumab
Memantine vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Memantine and Trastuzumab.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Memantine — 60-80 hours; Trastuzumab — 28 days.
Chemical Properties
Molecular Formula: Memantine — C12H21N.
Molecular Weight: Memantine — 179.3080 g/mol.
Type: Memantine — Small molecule; Trastuzumab — Antibody.